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The mammalian target of rapamycin (mTOR) complex 1 (mTORC1) senses a cell's energy status and
environmental levels of nutrients and growth factors. In response, mTORC1 mediates signaling that
controls protein translation and cellular metabolism. Although mTORC1 plays a critical role in hema-
topoiesis, it remains unclear which upstream stimuli regulate mTORC1 activity in the context of he-
matopoietic stem cells (HSC) maintenance in vivo. In this study, we investigated the function of Rheb, a
critical regulator of mTORC1 activity controlled by the PI3K-AKT-TSC axis, both in HSC maintenance in
mice at steady-state and in HSC-derived hematopoiesis post-transplantation. In contrast to the severe
hematopoietic dysfunction caused by Raptor deletion, which completely inactivates mTORC1, Rheb
deﬁciency in adult mice did not show remarkable hematopoietic failure. Lack of Rheb caused abnor-
malities in myeloid cells but did not have impact on hematopoietic regeneration in mice subjected to
injury by irradiation. As previously reported, Rheb deﬁciency resulted in defective HSC-derived hema-
topoiesis post-transplantation. However, while Raptor is essential for HSC competitiveness in vivo, Rheb
is dispensable for HSC maintenance under physiological conditions, indicating that the PI3K-AKT-TSC
pathway does not contribute to mTORC1 activity for sustaining HSC self-renewal activity at steady-
state. Thus, the various regulatory elements that impinge upstream of mTORC1 activation pathways
are differentially required for HSC homeostasis in vivo.
© 2017 Elsevier Inc. All rights reserved.1. Introduction
Hematopoietic stem cells (HSCs) are characterized by their
ability to both self-renew and differentiate into all lineages of blood





dical School and the Harvardensure hematopoiesis throughout an animal's entire lifespan but
also make bone marrow (BM) transplantation a viable therapy for
many hematologic disorders. Long-term HSCs are generally quies-
cent in their BM niches and undergo self-renewal only occasionally
in animals at steady-state. When a mouse suffers BM ablation or
acute blood loss, HSC proliferation and differentiation are induced
and hematopoietic progenitor cells (HPCs) are generated that
eventually differentiate into mature blood cells. Dysregulation of
the cell cycle in HSCs results in HSC exhaustion and defective he-
matopoiesis, emphasizing the fact that regulation of self-renewal is
critical for sustaining lifelong normal blood cell production [2].
Themammalian target of rapamycin (mTOR) is an evolutionarily
conserved serine/threonine protein kinase and belongs to the
phosphoinositide 3-kinase related kinase family. mTOR within a
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growth factors and signals intracellularly to coordinate cell meta-
bolism and growth. mTOR participates in two functionally distinct
complexes known as mTOR complex 1 (mTORC1) and mTORC2,
both of which phosphorylate multiple substrates [3]. mTORC1
contains three core components, namely mTOR, Raptor (regulatory
associated protein of mTOR), and mLST8 (mammalian lethal with
Sec13 protein 8), and plays a central role in cellular metabolism and
mRNA translation into protein. mTORC2 contains Rictor instead of
Raptor, and the mTORC2 signaling pathway regulates cytoskeletal
rearrangement and cell survival.
One of the main activators of mTORC1 is the PI3K-AKT-TSC
pathway [3]. Growth factors stimulate PI3K to generate phospha-
tidylinositol-3,4,5-triphosphate, which promotes the phosphory-
lation of AKT. Activated AKT then phosphorylates tuberous sclerosis
complex 2 (TSC2), a negative regulator of mTORC1, on multiple
sites. This phosphorylation of TSC2 blocks its GAP (GTPase-acti-
vating protein) activity, removing TSC2's inhibition of mTORC1 and
permitting mTORC1 activation, mediated by Rheb (Ras homolog
enriched in brain). mTORC1 can also be activated by a TSC-
independent pathway that is triggered by the presence of high
levels of amino acids in the surrounding microenvironment. Amino
acids induce the translocation of mTORC1 from the cell's cytoplasm
to the surface of its lysosomes. This translocation is regulated by
heterodimeric small Rag (Ras-related GTP binding) GTPases, each of
which consists of four highly conserved components: RagA, RagB,
RagC, and RagD [3,4]. Finally, an elevated ATP/AMP ratio within a
cell can stimulate mTORC1 by preventing the activation of AMP-
activated protein kinase (AMPK). Conversely, in response to low
energy supplies, AMPK phosphorylates Raptor and TSC2 (at a site
distinct from that phosphorylated by AKT), invoking mTORC1
suppression [3,4].
Emerging data from gene-targeted mouse models have revealed
that mTORC1 has a crucial role in HSC maintenance in vivo [5].
Hyperactivation of mTORC1 induced by deletion of Pten, which is a
negative regulator of the PI3K-AKT pathway, results in HSC
exhaustion [5,6]. Loss of Pten in murine HSCs induces short-term
expansion but long-term exhaustion, leading to the development
of myeloproliferative disorders and leukemia. Consistent with this
observation, hyperactivation of mTORC1 due to Tsc1 deletion in
mice also induces HSC depletion [5]. These ﬁndings clearly
demonstrate that mTORC1 plays a pivotal role in HSC maintenance.
However, it remains unclear which upstream stimuli regulate
mTORC1 activity in the context of HSC maintenance in vivo.
Rheb is a small GTP-binding protein that tightly regulates
mTORC1 activity induced via the PI3K-AKT-TSC pathway [7,8]. In
starved cells, Rheb is suppressed by the GAP activity of TSC2. When
nutrients or growth factors are supplied, PI3K is activated, which in
turn leads to the activation of AKT. Activated AKT phosphorylates
TSC2, inhibiting its GAP activity, and consequently activates Rheb,
which ultimately promotes mTORC1 activation. It was previously
reported that, in a Vav1-Cre transgenic mouse model, a well-
recognized and standard methodology for the analysis of hemato-
poietic cell-speciﬁc roles of molecules in vivo, Rheb deﬁciency
inhibited macrophage differentiation and reduced phagocytosis
ability of macrophages [9]. Additionally, loss of Rheb led to low
reconstitution activity of fetal liver-derived HSCs. However, since
Cre-mediated gene deletion in this system starts in the embryo
[10], it is therefore still uncertain whether Rheb is required for HSC
maintenance (self-renewal) in adult mice, because evidence is
accumulating that HSC behavior is regulated differently at different
developmental stages [11].
To understand the role of mTORC1 activity and regulation in HSC
maintenance in adult mice, we employed a tamoxifen-inducible
Cre-loxP system to demonstrate that, although mTORC1 activityitself is essential for HSC maintenance, Rheb-mediated mTORC1
activation is dispensable in vivo. These results suggest that mTORC1
activating pathways other than the PI3K-AKT-TSC axis can
contribute to HSC self-renewal under physiological conditions.2. Materials and methods
2.1. Mice
Rhebﬂox/ﬂox (RhebFl/Fl) mice [12] were backcrossed into the C57BL/
6 genetic background. RaptorFl/Fl [13] or RhebFl/Fl mice were crossed
with Rosa26-CreERT2 mice obtained from Dr. Tyler Jacks (Massa-
chusetts Institute of Technology, MA, USA). Congenic C57BL/6
(CD45.2) and C57BL/6-Ly5.1 (CD45.1) mice were purchased from
Sankyo Labo Service Corporation (Japan). Induction of CreERT2-
mediated DNA recombination was induced by intraperitoneal (i.p.)
injection of tamoxifen (TAM; Sigma) at 150 mg/kg per day for 5
consecutive days [13,14]. All animal experiments were approved by
the Committee on Animal Experimentation of Kanazawa Univer-
sity, and performed in accordance with the Guidelines for Animal
and Recombinant DNA Experiments of Kanazawa University.2.2. Hematological analysis
Peripheral blood was collected from the postorbital vein, and
Complete Blood Count (CBC) analysis was performed. Bonemarrow
mononuclear cells (BMMNCs) were prepared from femoral and
tibial bones as previously reported [13,14].2.3. Competitive repopulation assay
Competitive repopulation assays were performed as described
previously [13,14]. Brieﬂy, tester BMMNCs (CD45.2) were mixed
with an equal number of competitors [wild-type (WT) BMMNCs;
CD45.1/CD45.2], and the mixture was transplanted into lethally
irradiated (9 Gy) WT recipient mice (CD45.1). Donor-derived he-
matopoietic cells were analyzed for their surface expression of
CD45.1 or CD45.2 by ﬂow cytometry. For the BM radioprotection
assay, mice were irradiated at a sub-lethal dose (4 Gy).2.4. Flow cytometry
Monoclonal antibodies recognizing the following cell surface
markers were used for ﬂow cytometry: Sca-1, CD4, CD8, B220,
TER119, Gr-1, Mac-1, IL7Ra chain, FcgIII/II receptor, CD34, CD45.1,
CD45.2, CD41, c-KIT, and IgM. All antibodies were purchased from
BD Biosciences or eBiosciences.
For analysis of intracellular proteins, cells were ﬁxed and stained
as described previously [13]. Antibodies used were: Alexa488-
conjugated antiephospho-S6 (S235/236), antiephospho-4E-BP1
(T37/46), and isotype-matched rabbit IgG control. All antibodies
were purchased from Cell Signaling Technology.2.5. Colony formation assay
Cells (1  103) were incubated in triplicate in MethoCult
(STEMCELL Technologies) as previously described [13,14]. Total
colony numbers were counted after 7 days. For quantiﬁcation of
gene deletion efﬁciency in hematopoietic stem and progenitor cells
(HSPCs; LinSca-1þc-kitþ, LSK), single cell-derived colonies were
picked individually and genotyped as described previously [12].
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3.1. Rheb deﬁciency causes abnormalities in myeloid lineage cells
but does not lead to severe hematopoietic failure in adult mice
To investigate mTORC1 function in adult hematopoiesis in vivo,Fig. 1. Loss of Rheb induces myeloid population expansion but no severe hematopoietic ab
(a) Absolute numbers of WBC in RhebFl/Fl, RhebFl/wt;Rosa-CreERT2 and Rhebwt/wt;Rosa-CreERT
administration. Data points are values for individual mice (n ¼ 6 for control and n ¼ 13 fo
(b) Absolute numbers of myeloid cells (Mac-1þ), B cells (B220þ), and T cells (CD4þ/CD8þ)
*P < 0.05 (Student's t-test).
(c) Frequencies of B lineage cells (B220/IgM) and myeloid lineage cells (Mac-1/Gr-1) in B
mean ± SEM (n ¼ 3).
(d) Flow cytometric analysis of the frequencies of the LinSca-1þc-Kitþ (LSK, HSPC), Lin-c-
KitþSca-1CD34FcgRII/III (MEP) cells in BM from control and RhebD/D mice at 6 weeks p
(e) Representative image of splenomegaly and weights of spleens isolated from control and R
group). Horizontal lines are the mean ± SEM.
(f) Absolute numbers of LSK, GMP, CMP, and MEP cells and frequencies of the indicated m
treatment. Data are the mean ± SEM (n ¼ 3).we established a TAM-inducible CreERT2 system to generate Rap-
torFl/Fl;Rosa-CreERT2 mice and RhebFl/Fl;Rosa-CreERT2 mice in which
Raptor or Rheb, respectively, could be depleted in all tissues by i.p.
injection of TAM. In this paper, RhebFl/Fl, RhebFl/wt;Rosa-CreERT2 and
Rhebwt/wt;Rosa-CreERT2 mice with TAM treatment are used as con-
trols, and RhebFl/Fl;Rosa-CreERT2 mice after TAM administration arenormalities in adult mice.
2 (control) and RhebFl/Fl;Rosa-CreERT2 (RhebD/D) mice at the indicated times after TAM
r RhebD/D group).
in PB of the mice at 6 weeks post-TAM treatment. Data are the mean ± SEM (n ¼ 3).
M from the control and RhebD/D mice at 6 weeks post-TAM treatment. Data are the
KitþSca-1CD34þFcgRII/IIIþ(GMP), Lin-c-KitþSca-1CD34þFcgRII/III (CMP) and Lin-c-
ost-TAM treatment. Data are representative of n ¼ 3 mice per group.
hebD/Dmice at 6 weeks post-TAM treatment. Data are values for individual mice (n ¼ 6/
yeloid lineage cells in spleens from control and RhebD/D mice at 6 weeks post-TAM
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CreERT2 (RaptorD/D) mice died within 20 days after TAM injection
[13]. However, all of our RhebD/D mutants survived long-term as
apparently normal mice, despite their complete deletion of the
Rheb gene (Supplementary Fig. 1a, b and d). When we analyzed
hematopoiesis in these mutants, we found that Rheb deﬁciency had
induced a signiﬁcant increase in the total number of white blood
cells (WBCs) in peripheral blood (PB), and especially in the Mac-1þ
myeloid population (Fig. 1a and b; Supplementary Table 1). In BM,
Rheb deﬁciency led to signiﬁcant decreases in B220lowIgMþ B cells
(immature B cells), although Mac1þGr-1- myeloid lineage cells
were increased (Fig. 1c). The number of granulocyte-macrophage
progenitors (GMPs) was also elevated, but number of HSPCs in
RhebD/D mice was comparable to those in controls (Fig. 1d,
Supplementary Fig. 1c), a ﬁnding paralleling previous studies of
Raptor-deﬁcient mice [13]. RhebD/D mice exhibited splenomegaly
and marked increases in undifferentiated hematopoietic cell pop-
ulations in the spleen, including HSPCs, GMPs, common myeloid
progenitors (CMPs), and megakaryocyte-erythroid progenitors
(MEPs) (Fig. 1e and f). Mac1þGr-1- myeloid lineage cells were also
increased in RhebD/D spleen, consistent with their elevation in PB.
These data demonstrate that Rheb is important for the develop-
ment of myeloid cells.
3.2. Rheb deﬁciency impairs HSC-derived hematopoiesis post-
transplantation but has no impact on hematopoietic regeneration
after irradiation-induced injury
To evaluate the effect of Rheb deﬁciency on HPSC function, we
isolated LSK cells from the BM of RhebD/Dmice and cultured them inFig. 2. Rheb-deﬁcient HSCs show a defect in repopulating capacity following transplantatio
(a) Colony-forming assay of LSK cells sorted from BM of control or RhebD/D mice at 4 week
(b) Percentage of donor-derived cells in PB of recipient mice that received control or RhebD/D
post-transplantation. Data are the mean ± SEM (n ¼ 7). **P < 0.01 (Student's t-test).
(c) Percentage of donor-derived LSK cells in BM of the recipient mice in (b) at 16 weeks po
(def) Total numbers of (d) WBC, (e) RBC, and (f) PLT in control and RhebD/D mice that under
indicated days post-irradiation. Data are the mean ± SEM (n ¼ 5).semi-solidmedium in a colony formation assay. Loss of Rheb did not
dramatically affect the formation of macrophage/granulocyte col-
onies (Fig. 2a). Because Raptor deﬁciency causes a severe defect in
colony formation [13], this result implied that the mTORC1 acti-
vation essential for the proliferation of HSPCs was not dependent
on Rheb. To evaluate HSC function in this context, we performed a
standard competitive transplantation assay by combining BM cells
(CD45.2) from control or RhebD/D (i.e. TAM-treated) mice with an
equal number of WT competitor cells (CD45.1/CD45.2) and
implanting them in the BM of lethally irradiatedWT recipient mice
(CD45.1) (Supplementary Fig. 2a). At 4 weeks post-transplantation,
the proportion of Rheb-deﬁcient cells (tester-derived cells) was
signiﬁcantly reduced in PB of recipients compared to control cells
(Fig. 2b, Supplementary Fig. 2bed). At 16 weeks post-
transplantation, the degree of chimerism due to tester-derived
LSK cells was also reduced (Fig. 2c), indicating that Rheb deﬁ-
ciency causes a defect in HSC-derived hematopoiesis post-
transplantation.
Next, to investigate whether Rheb-deﬁcient HSCs retain their
repopulating capacity after hematopoietic injury, we examined
hematopoietic regeneration in control and mutant mice exposed to
sub-lethal whole body irradiation (4 Gy). While highly proliferative
HSPC are sensitive to irradiation, quiescent WT HSCs are largely
resistant and survive to re-establish hematopoiesis post-irradiation
[15]. We found that, in control mice, hematopoietic mature cells
were drastically decreased a few days after irradiation, but that
hematopoiesis then rapidly recovered due to the proliferation and
differentiation of HSCs (Fig. 2def). In irradiated mutant mice,
although red blood cells (RBCs) and platelets (PLTs) were slightly
decreased in number at a few time points, Rheb-deﬁcient HSCsn but not irradiation.
s post-TAM treatment. Data are the mean ± SEM (n ¼ 3). NS, not signiﬁcant.
BMMNCs in competition with WT BMMNCs and were examined at the indicated times
st-transplantation. Data are the mean ± SEM (n ¼ 3).
went BM ablation by irradiation at a sub-lethal dose (4 Gy) and were examined on the
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in irradiated control mice. Similarly, the frequency and colony-
forming ability of the regenerated HSPC population in irradiated
Rheb-deﬁcient mice was not signiﬁcantly different from that in
irradiated controls (Supplementary Fig. 2e and f). These data sug-
gest that Rheb dependency varies with the type of hematopoietic
stress, and imply that Rheb may not necessarily be required for
in vivo HSC self-renewal in mice at steady-state.
3.3. Rheb contributes modestly to the activation of mTORC1 in
HSPCs
To investigate the effects of Rheb deﬁciency on mTORC1
signaling, we quantitatively evaluated the phosphorylation status
of mTORC1 effectors by ﬂow cytometric analysis of cells subjected
to intracellular staining with antiephospho-4E-BP1 (T37/46) anti-
body, because these phosphorylation sites are the representative
direct targets of mTORC1. The phosphorylation of 4E-BP1 was
signiﬁcantly decreased in Rheb-deﬁcient LSK cells (Fig. 3), although
the degree of this suppression was milder than that exerted by
Raptor deﬁciency (Fig. 3). The levels of phosphorylation of S6 (S235/
236), an indirect target of mTORC1, in control, Rheb-deﬁcient and
Raptor-deﬁcient LSK cells were comparable, although there was
variability among samples (data not shown). Thus, Rheb contrib-
utes modestly to the activation of mTORC1 in HSPCs.
3.4. Rheb-dependent mTORC1 activity is dispensable for HSC self-
renewal in mice at steady-state
To investigate whether Rheb-mediated mTORC1 activity was
required for the physiological self-renewal of HSCs in vivo, we
quantitatively evaluated the chimerism of the HSC population in
recipient mice in which deletion of Rheb or Raptor was induced by
TAM treatment after transplantation. To this end, we mixed Rap-
torFl/Fl;Rosa-CreERT2 or RhebFl/Fl;Rosa-CreERT2 BMMNCs (CD45.2)
with an equal number of competitor WT BMMNCs (CD45.1/CD45.2)
and transplanted these cells intoWT recipient mice (CD45.1). These
animals were then i.p. injected with TAM at 8 weeks post-
transplantation (Supplementary Fig. 3a). Prior to TAM treatment,
no signiﬁcant difference was observed in the engraftment ofFig. 3. mTORC1 activity is only modestly suppressed by Rheb deﬁciency.
(left) Intracellular FACS staining for phosphorylated 4E-BP1 in LSK cells isolated from
BM of control, RhebD/D and RaptorD/D mice. RhebD/D, n ¼ 3; RaptorD/D, n ¼ 4; control,
n ¼ 3; IgG (negative control), n ¼ 1. (right) Phosphorylation level of 4E-BP1 expressed
as the mean ± SEM (n ¼ 3) of median ﬂuorescence intensity (MFI). ***P < 0.001
(Student's t-test).RaptorFl/Fl;Rosa-CreERT2 or RhebFl/Fl;Rosa-CreERT2 cells compared to
WTcompetitor cells (Fig. 4a and b). However, by 2 weeks post-TAM
treatment, examination of PB revealed a signiﬁcant decline in the
ratios of hematopoietic cells derived from Raptor-deﬁcient HSCs
(Fig. 4a). By 4e16 weeks post-TAM treatment, Raptor deﬁciency had
led to a progressive reduction in all hematopoietic lineages,
including HSCs (Fig. 4a and d). Thus, long-term inactivation of
mTORC1 due to loss of Raptor profoundly impaired the regenera-
tion of multiple hematopoietic lineages as well as HSC self-renewal,
consistent with previous reports [16]. However, loss of Rheb did not
reduce almost all lineages of hematopoietic cells, including HSCs
(Fig. 4b and e), indicating that HSC self-renewal is not dependent on
Rheb under normal physiological conditions.
To investigate the function of Rheb-deﬁcient HSCs under con-
ditions of physiological stress, a mixture of RhebFl/Fl;Rosa-CreERT2
BMMNCs (CD45.2) and WT competitor BMMNCs (CD45.1/CD45.2)
was transplanted into WT recipients (CD45.1). These animals were
treated with TAM at 8 weeks post-transplantation and then sub-
jected to sub-lethal irradiation (4 Gy) (Supplementary Fig. 3b). We
found that the degree of hematopoietic chimerism in the recipients
was not altered by irradiation (Fig. 4c and f), indicating that Rheb
deﬁciency does not affect physiological HSC behavior even under
stress conditions. These data clearly demonstrate that, despite
Rheb's contribution to mTORC1 signaling, HSC self-renewal in vivo
does not require Rheb-dependent mTORC1 activation under either
steady-state or stress conditions.
4. Discussion
By using a TAM-inducible Cre-loxP mouse model, we have
demonstrated that loss of Rheb causes abnormalities in myeloid cell
development but does not lead to a remarkable failure of adult
hematopoiesis. Unlike the severe hematopoietic defect induced by
mTORC1 inactivation due to Raptor deletion, Rheb deﬁciency results
in defective HSC-derived hematopoiesis post-transplantation but
has no impact on BM regeneration after hematopoietic injury.
Moreover, while Raptor is essential for physiological HSC mainte-
nance, Rheb is dispensable for HSC self-renewal in mice either at
steady-state or under stress conditions. Therefore, the requirement
for Rheb function in hematopoiesis is highly context-dependent.
We and another group have independently reported that com-
plete inactivation of mTORC1 due to Raptor deﬁciency results in BM
accumulations of GMPs and monocytes and defective granulocyte
differentiation [13,16]. Recently, Wang et al. reported that a popu-
lation of Mac-1þ myeloid cells is decreased in the liver of fetal
RhebFl/Fl;Vav1-Cremice [9]. In contrast, adult RhebFl/Fl;Vav1-Cremice
show an increased absolute number of Mac-1þ myeloid cells,
including granulocytes and monocytes, but a defect in the matu-
ration of monocytes into functional macrophages. Consistent with
this ﬁnding, our experiments using our TAM-inducible knockout
model showed that a lack of Rheb in adult mice increases the
number of GMPs and total myeloid cells. These data indicate that
Rheb-dependent mTORC1 signaling is important for myeloid line-
age differentiation. We also observed splenomegaly and elevations
in the Mac-1þ, HSC and GMP populations in Rheb-deﬁcient spleen,
abnormalities that were not reported for RhebFl/Fl;Vav1-Cre adult
mice. This result suggests that extrinsic deletion of Rheb in non-
hematopoietic cells may contribute to the myeloid abnormality.
We and another group have also independently reported that
mTORC1 plays a critical role in HSC repopulation activity [14,16].
However, it was not determined how modiﬁcation of mTORC1's
activation status might contribute to HSC maintenance in vivo. Our
experimental approach has clearly established that complete loss of
mTORC1 signaling (due to loss of Raptor) results in severe defects in
both steady-state hematopoiesis and hematopoietic regeneration
Fig. 4. Rheb-dependent mTORC1 activity is dispensable for the maintenance of HSC function in mice at steady-state or after irradiation-induced injury.
(a, b) Chimerism of donor-derived cells in PB of recipient mice that were transplanted with control BMMNCs, or BMMNCs from (a) RaptorFl/Fl;Rosa-CreERT2 or (b) RhebFl/Fl;Rosa-
CreERT2 mice, in competition with WT BMMNCs, and were examined at the indicated time points after TAM treatment. Data are the mean ± SEM (n ¼ 4e6 recipients).
(c) Chimerism of donor-derived cells in PB of recipient mice that were transplanted with BMMNCs from RhebFl/Fl;Rosa-CreERT2 mice in competition with WT BMMNCs, and were
treated with TAM at 8 weeks post-transplantation. The animals were then subjected to injury by sub-lethal irradiation and examined at the indicated times after irradiation. Data
are the mean ± SEM (n ¼ 7).
(d, e) Chimerism of LSK cells and the indicated lineage cells in BM of (d) the recipients in (a), or (e) the recipients in (b), at 16 weeks post-TAM treatment. Data are the mean ± SEM
(n ¼ 3).
(f) Chimerism of HSPCs and the indicated lineage cells in the recipients in (c) at 16 weeks post-irradiation. Data are the mean ± SEM (n ¼ 3e6).
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activity due to Rheb deletion does not impair normal hematopoiesis
but does reduce the repopulating activity of HSCs transplanted into
irradiated recipient mice. Our results imply that distinct mTORC1-
activating mechanisms exist to maintain HSCs in steady-state ani-
mals (homeostasis) as opposed to those undergoing the acute stress
of transplantation.
It is unclear how mTORC1 is activated by Rheb independent
pathways in HSCs at steady-state. Receptor tyrosine kinases (RTKs)
activate mTORC1 via not only AKT-TSC pathway but also Ras-Erk
cascade [4]. In response to cytokines, Erk and Rsk protein kinases
suppress TSC2 by phosphorylating speciﬁc residues, suggesting
that the Ras-Erk pathway may contribute to mTROC1 activation in
HSCs. In addition, Wnt/beta-catenin signaling is critical for HSC
maintenance and activates mTORC1 by suppressing TSC1 [3,4].
Alternatively, Rag GTPases are capable of mTORC1 activation in a
PI3K-AKT-TSC-independent manner [3]. Based on our ﬁndings,
Rheb-independent mTORC1 activation is sufﬁcient for HSC main-
tenance in animals at steady-state, but both Rheb-dependent and
Rhebeindependent pathways of mTORC1 activation are required
for successful HSC function following transplantation. It has been
recently reported that HSCs are sensitive to amino acid restriction,
and that a dietary deﬁciency of valine, one of the essential aminoacids, can dramatically reduce HSCs in WT mice within one week
[17]. Our data suggest that a Rheb-independent, nutrient-depen-
dent signaling pathway may be essential for HSC maintenance in
both the steady-state and transplantation situations. Furthermore,
the process of transplantation itself is a stressful event for HSCs.
During serial transplantations, levels of intracellular reactive oxy-
gen species (ROS) become elevated and DNA damage accumulates
in HSCs, resulting in premature senescence of these cells and loss of
stemness [18,19]. Therefore, both Rheb-dependent and Rheb-
independent mTORC1 activation pathways may be necessary to
defend HSCs against the stress imposed by transplantation.
In conclusion, this study deﬁnitively establishes that Rheb is
required for HSC function following transplantation but is
dispensable for HSC self-renewal under physiological conditions.
Further dissection of the molecular mechanisms in each of these
contexts is required to fully understand not only HSC maintenance
but also HSC aging and resistance to transplantation stress. Such
knowledge may lead to improved clinical therapies for hemato-
logical disorders involving HSCs.
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